On June 24, 2022, AbbVie shared findings from the newly launched Emotional Impact Report, a survey of more than 300 chronic lymphocytic leukemia (CLL) patients, caregivers and healthcare providers (HCPs) in the U.S., which uncovered insights about the emotional journey associated with a CLL diagnosis.
<< Back